Issues Related to Monitoring the Safety of Over-The-Counter (OTC) Medicines

Author： Bond C.   Hannaford P.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.26, Iss.15, 2003-01, pp. : 1065-1074

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Over‐the‐Counter Status of Medicines

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 39, Iss. 2, 2009-06 ,pp. : 91-91

John Wiley & Sons Inc

Access to resources Recommend Favorite

A new US government regulation requiring a standardised label on most over-the-counter (OTC) medicines

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 363, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Global over-the-counter (OTC) drug sales for Novartis rose 5% in 2001

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 350, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Clinical Significance of Pharmacokinetic Drug Interactions with Over-the-Counter (OTC) Drugs

By Honig P.K.  

Clinical Pharmacokinetics, Vol. 35, Iss. 3, 1998-09 ,pp. : 167-171

Adis International

Access to resources Recommend Favorite

Availability of triptans over-the-counter (OTC) for the treatment of migraine has advantages and disadvantages

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 8, 2008-08 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite